Pharmaceutical composition suitable for treatment of inflammatory changes of the bronchial mucosa
US4606920A · kind A · utility
10Cited by
1References
2Claims
0Family size
Inventor
Key dates
| Filing date | Mar 2, 1984 |
| Grant date | Aug 19, 1986 |
| Priority date | — |
| Expiry date | Mar 2, 2004 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition is being described that contains pharmacologically acceptable magnesium compounds, etofylline, vitamin A and vitamin C. It is especially suitable for treatment of inflammatory changes of the bronchial mucosa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.